Apitope will be attending Knowledge for Growth, organized by FlandersBio on the 30th of May in Gent. We look forward to meeting you there. More information on the event can be found here: knowledgeforgrowth.be
Apitope is participating at the 20th BIO International Convention organized April 22nd – 25th in Chicago, USA. Dr. Hayley French, Commercial Director will be attending and is looking forward to discussing the Apitope portfolio with potential partners.
We are pleased to announce that Apitope’s CEO, Keith Martin will be presenting at BioCapitalEurope.
Apitope will be attending the 7th Annual International Partnering Conference ‘Bio Europe Spring® 2013′. We will be happy to meet with you to discuss potential partnerships.
Apitope International N.V., the biopharmaceutical company developing peptide therapies for autoimmune diseases, is pleased to announce that Dr. Keith Martin, CEO, will provide an update on Apitope (antigen processing independent epitope autoimmune vaccines) at the symposium on “Therapeutic & Preventative Vaccines for Autoimmune Diseases: Scientific & Commercial Opportunities”, sponsored by the Juvenile Diabetes Research Foundation and Fast Forward, LLC.
Dr. Martin will present at the Hilton San Francisco, Union Square, at 2.45pm (PST) on Sunday, 9 January 2011, prior to the J.P. Morgan Healthcare Conference.
The symposium will feature leading researchers and experts on autoimmune vaccines, presenting the latest scientific and technological knowledge and insight into this emerging field.
Apitope International N.V., the autoimmune peptide therapy company, announces today that Dr. Keith Martin, CEO,will give an overview of the Company’s business at ‘BioEquity Europe 2010’.
The presentation will be at the Swissôtel Zurich, Switzerland at 15.30 (CET) on Wednesday, 19 May 2010.
The presentation will focus on Apitope’s development of therapeutic peptides for revolutionary treatment of autoimmune diseases and allergies.
Apitope International N.V., the autoimmune peptide therapy company, announced today that Dr. Keith Martin, CEO, will give an overview of the Company’s business at ‘The Peptide Conference’. The presentation will be at The Wellcome Trust Conference Centre, Cambridge, UK at 4pm (BST) on Tuesday, 30th March 2010.
The presentation will provide an insight into how Apitope designs and develops therapeutic peptides for revolutionary treatment of autoimmune diseases and allergies.
The conference will feature leading researchers and experts from the various fields of peptide therapeutics development, presenting the latest scientific and technological knowledge in these rapidly advancing areas of life sciences. The applications of peptide chemistry from synthesis through purification and analytics,bioactivity testing in biotechnology, biomedical and other applications from nalytical to industrial scales will be presented.